Although the PERK pathway has been found to be involved in AD (Rozpedek et al. 2015; Yang et al. 2016), in this study, we focused on specific responses activated by IRE1α-XBP1 and ATF6 pathways which share several target genes. This evidence concerns the gene EIF2AK3 and Alzheimer disease.